Cargando…
Targeting ERK-Hippo Interplay in Cancer Therapy
Extracellular signal-regulated kinase (ERK) is a part of the mitogen-activated protein kinase (MAPK) signaling pathway which allows the transduction of various cellular signals to final effectors and regulation of elementary cellular processes. Deregulation of the MAPK signaling occurs under many pa...
Autores principales: | Vališ, Karel, Novák, Petr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247570/ https://www.ncbi.nlm.nih.gov/pubmed/32375238 http://dx.doi.org/10.3390/ijms21093236 |
Ejemplares similares
-
The MEK-ERK-MST1 Axis Potentiates the Activation of the Extrinsic Apoptotic Pathway during GDC-0941 Treatment in Jurkat T Cells
por: Nováková, Jana, et al.
Publicado: (2019) -
Targeting the Hippo Pathway for Breast Cancer Therapy
por: Wu, Liqing, et al.
Publicado: (2018) -
Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018) -
Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
por: Juan, Wen Chun, et al.
Publicado: (2016) -
Interplay of Developmental Hippo–Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer
por: Mourkioti, Ioanna, et al.
Publicado: (2022)